サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439905

臨床化学分析装置 - 世界市場の考察、競合情勢、市場予測（2030年）

Clinical Chemistry Analyzers - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床化学分析装置 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床化学分析装置の市場規模は、2022年に123億8,000万米ドル、2030年までに163億9,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.82%の成長が見込まれます。市場は、慢性疾患の流行や老年人口の増加といった要因によって大幅な成長を示しています。さらに、疾病の早期診断への需要の急増、ポイントオブケア検査の重要性と認知度の向上、製品の上市と承認の増加に伴う装置の技術の急速な進歩、市場における主要企業のプレゼンスなどの要因が、市場における臨床化学分析装置の要件を生み出します。したがって、市場は2024年～2030年の予測期間に大幅なCAGRで成長すると推定されます。

臨床化学分析装置の市場力学

臨床化学分析装置市場の重要な促進要因の1つは、世界中でのがん、泌尿器科疾患、感染症などのさまざまな慢性疾患の増加です。

例えば、世界保健機関（WHO）（2022）によると、慢性疾患により毎年4,100万人近くが死亡しており、これは世界全体の死亡者数の74%に相当します。慢性疾患の主な種類は、心臓発作や脳卒中などの心血管疾患、がん、慢性閉塞性肺疾患や喘息などの慢性呼吸器疾患、糖尿病などです。

また、同資料は2020年における世界全体のがんの発症数も示しています。もっとも多いのは乳がんで226万人、肺がん221万人、大腸がん193万人、前立腺がん141万人、皮膚がん120万人、胃がん109万人です。このようながんの罹患率の増加は、がんの診断に使用できる分析装置の需要を増加させ、市場での高い需要につながります。

また、老年人口の増加により慢性疾患の有病率が高まり、臨床化学分析装置の需要も増加します。WHOが2022年に発表した調査によると、2030年までに6人に1人が60歳以上になると明言されています。同調査によれば、60歳以上の人口は2020年の10億人から2030年までに14億人に達します。さらに、この数字は2050年までに21億人になると予測されています。増加している老年人口は複数の慢性疾患に罹患しやすく、その結果、臨床検査の需要が高まります。そのため、臨床化学分析装置市場は予測期間に高い成長が見込まれます。

さらに、臨床化学分析装置に関連する製品の発売や承認の増加により、今後数年間に装置の需要が促進されます。例えば、2022年7月、医療用電子装置を提供するEDAN Instruments, Inc.は、血液ガスから電解質、COオキシメトリまでカバーする45超のパラメーターを分析する能力を備えたポイントオブケア（POC）蛍光ベースのCO-OX血液ガス・化学分析システム、i20を発売しました。

したがって、上記の要因が2024年～2030年の予測期間に臨床化学分析装置市場全体を牽引します。

しかし、訓練を受けた熟練した専門家の不足や臨床化学分析装置の高いコストなどが、臨床化学分析装置市場の成長にとっての課題となる可能性があります。

臨床化学分析装置市場は、COVID-19パンデミック期間中に中程度の影響を受けた。感染拡大を抑制するために世界各国の政府が厳しいロックダウン規則を課したため、市場ではサプライチェーンや原材料などのリソースが不足し、すべての医療装置の製造が減少しました。さらに、患者や医師は、感染の拡大を食い止めるために、多くの選択的手術、検査、疾患の診断を延期し、その結果、病院や診療所での入院患者数が減少しました。しかし、COVID-19のワクチン開発により、ロックダウン規制が緩和され、経済情勢が正常化したことで、病院や診療所での治療、管理、診断に向けた定期的な外来受診など、通常の医療サービスが再開されるようになり、臨床化学分析装置市場における製品需要が軌道に乗ってきました。

臨床化学分析装置市場のセグメント分析

臨床化学分析装置市場の製品タイプセグメントでは、2023年に分析装置セグメントが大きな収益シェアを占めると予測されています。その主な理由は、慢性疾患の増加、市場における先進技術を利用した製品の利用可能性、製品の上市と承認の増加などの、このセグメントが提供する利点です。

当レポートでは、世界の臨床化学分析装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 臨床化学分析装置市場レポートのイントロダクション

第2章 臨床化学分析装置市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 臨床化学分析装置市場の主な要因の分析

  • 臨床化学分析装置市場の促進要因
    • 慢性疾患の流行
    • 老年人口の負担の増加
    • ポイントオブケア検査の重要性と意識の高まり
    • 臨床化学分析装置の技術の進歩
  • 臨床化学分析装置市場の抑制要因と課題
    • 訓練を受けた熟練した専門家の不足
    • 臨床化学分析装置の高いコスト
  • 臨床化学分析装置市場の機会
    • 早期の正確な診断に対する需要と意識の高まり
    • 装置へのAIの組み込み

第5章 臨床化学分析装置市場のポーターのファイブフォース分析

第6章 臨床化学分析装置市場に対するCOVID-19の影響分析

第7章 臨床化学分析装置の市場レイアウト

  • 製品タイプ別
    • 分析装置
    • 試薬
    • その他
  • 検査タイプ別
    • 肝臓パネル
    • 電解質パネル
    • 甲状腺機能パネル
    • 脂質プロファイル
  • 技術別
    • 全自動
    • 半自動
  • エンドユーザー別
    • 病院
    • 診断検査室
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 臨床化学分析装置市場：世界の企業シェア分析 - 主な3～5社

第9章 臨床化学分析装置市場の企業と製品のプロファイル

  • Abbott
  • Beckman Coulter, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • Sysmex Europe SE.
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd.
  • HORIBA Medical
  • Johnson & Johnson Services, Inc.
  • Randox Laboratories Ltd.
  • Ortho Clinical Diagnostics.
  • Nova Biomedical
  • BioSystems Diagnostics Pvt. Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Diatron.
  • EKF Diagnostics Holdings plc
  • Medica Corporation.
  • Trivitron Healthcare
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market
  • Table 3 Clinical Chemistry Analyzers Market Analysis in Global (2021-2030)
  • Table 4 Clinical Chemistry Analyzers Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Clinical Chemistry Analyzers Market Analysis in Global by Type of Test (2021-2030)
  • Table 6 Clinical Chemistry Analyzers Market Analysis in Global by Technology (2021-2030)
  • Table 7 Clinical Chemistry Analyzers Market Analysis in Global by End-user (2021-2030)
  • Table 8 Clinical Chemistry Analyzers Market Analysis in Global by Geography (2021-2030)
  • Table 9 Clinical Chemistry Analyzers Market Analysis in North America (2021-2030)
  • Table 10 Clinical Chemistry Analyzers Market Analysis in North America by Country (2021-2030)
  • Table 11 Clinical Chemistry Analyzers Market Analysis in the US (2021-2030)
  • Table 12 Clinical Chemistry Analyzers Market Analysis in Canada (2021-2030)
  • Table 13 Clinical Chemistry Analyzers Market Analysis in Mexico (2021-2030)
  • Table 14 Clinical Chemistry Analyzers Market Analysis in Europe (2021-2030)
  • Table 15 Clinical Chemistry Analyzers Market Analysis in Europe by Country (2021-2030)
  • Table 16 Clinical Chemistry Analyzers Market Analysis in France (2021-2030)
  • Table 17 Clinical Chemistry Analyzers Market Analysis in Germany (2021-2030)
  • Table 18 Clinical Chemistry Analyzers Market Analysis in the UK (2021-2030)
  • Table 19 Clinical Chemistry Analyzers Market Analysis in Italy (2021-2030)
  • Table 20 Clinical Chemistry Analyzers Market Analysis in Spain (2021-2030)
  • Table 21 Clinical Chemistry Analyzers Market Analysis in Rest of Europe (2021-2030)
  • Table 22 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific (2021-2030)
  • Table 23 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24 Clinical Chemistry Analyzers Market Analysis in China (2021-2030)
  • Table 25 Clinical Chemistry Analyzers Market Analysis in Japan (2021-2030)
  • Table 26 Clinical Chemistry Analyzers Market Analysis in India (2021-2030)
  • Table 27 Clinical Chemistry Analyzers Market Analysis in Australia (2021-2030)
  • Table 28 Clinical Chemistry Analyzers Market Analysis in South Korea (2021-2030)
  • Table 29 Clinical Chemistry Analyzers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 30 Clinical Chemistry Analyzers Market Analysis in Rest of World (2021-2030)
  • Table 31 Clinical Chemistry Analyzers Market Analysis in Rest of World by Region (2021-2030)
  • Table 32 Clinical Chemistry Analyzers Market Analysis in the Middle East (2021-2030)
  • Table 33 Clinical Chemistry Analyzers Market Analysis in Africa (2021-2030)
  • Table 34 Clinical Chemistry Analyzers Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market
  • Figure 3 Clinical Chemistry Analyzers Market Analysis in Global (2021-2030)
  • Figure 4 Clinical Chemistry Analyzers Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Clinical Chemistry Analyzers Market Analysis in Global by Type of Test (2021-2030)
  • Figure 6 Clinical Chemistry Analyzers Market Analysis in Global by Technology (2021-2030)
  • Figure 7 Clinical Chemistry Analyzers Market Analysis in Global by End-user (2021-2030)
  • Figure 8 Clinical Chemistry Analyzers Market Analysis in Global by Geography (2021-2030)
  • Figure 9 Clinical Chemistry Analyzers Market Analysis in North America (2021-2030)
  • Figure 10 Clinical Chemistry Analyzers Market Analysis in North America by Country (2021-2030)
  • Figure 11 Clinical Chemistry Analyzers Market Analysis in the US (2021-2030)
  • Figure 12 Clinical Chemistry Analyzers Market Analysis in Canada (2021-2030)
  • Figure 13 Clinical Chemistry Analyzers Market Analysis in Mexico (2021-2030)
  • Figure 14 Clinical Chemistry Analyzers Market Analysis in Europe (2021-2030)
  • Figure 15 Clinical Chemistry Analyzers Market Analysis in Europe by Country (2021-2030)
  • Figure 16 Clinical Chemistry Analyzers Market Analysis in France (2021-2030)
  • Figure 17 Clinical Chemistry Analyzers Market Analysis in Germany (2021-2030)
  • Figure 18 Clinical Chemistry Analyzers Market Analysis in the UK (2021-2030)
  • Figure 19 Clinical Chemistry Analyzers Market Analysis in Italy (2021-2030)
  • Figure 20 Clinical Chemistry Analyzers Market Analysis in Spain (2021-2030)
  • Figure 21 Clinical Chemistry Analyzers Market Analysis in Rest of Europe (2021-2030)
  • Figure 22 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24 Clinical Chemistry Analyzers Market Analysis in China (2021-2030)
  • Figure 25 Clinical Chemistry Analyzers Market Analysis in Japan (2021-2030)
  • Figure 26 Clinical Chemistry Analyzers Market Analysis in India (2021-2030)
  • Figure 27 Clinical Chemistry Analyzers Market Analysis in Australia (2021-2030)
  • Figure 28 Clinical Chemistry Analyzers Market Analysis in South Korea (2021-2030)
  • Figure 29 Clinical Chemistry Analyzers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 30 Clinical Chemistry Analyzers Market Analysis in Rest of World (2021-2030)
  • Figure 31 Clinical Chemistry Analyzers Market Analysis in Rest of World by Region (2021-2030)
  • Figure 32 Clinical Chemistry Analyzers Market Analysis in the Middle East (2021-2030)
  • Figure 33 Clinical Chemistry Analyzers Market Analysis in Africa (2021-2030)
  • Figure 34 Clinical Chemistry Analyzers Market Analysis in South America (2021-2030)
  • Figure 35 Market Drivers
  • Figure 36 Market Barriers
  • Figure 37 Market Opportunities
  • Figure 38 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0582

CLINICAL CHEMISTRY ANALYZERS MARKET BY PRODUCT TYPE (ANALYZERS, REAGENTS, AND OTHERS), BY TYPE OF TEST (LIVER PANELS, ELECTROLYTE PANELS, THYROID FUNCTION PANELS, LIPID PROFILES, AND OTHERS), BY TECHNOLOGY (FULLY-AUTOMATED AND SEMI- AUTOMATED), BY END USER (HOSPITAL, DIAGNOSTIC LABORATORIES, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO ADVANCE AT A RESPECTABLE CAGR FORECAST till 2030 OWING TO THE INCREASING PREVALENCE OF VARIOUD CHORNIC DIESAES AND ESCALTING BURDEN OF GERATRIC POPULATION ACROSS THE GLOBE

The global clinical chemistry analyzers market was valued at USD 12.38 billion in 2022 and will grow at a CAGR of 4.82% during the forecast period from 2024 to 2030 in order to reach USD 16.39 billion by 2030. The clinical chemistry analyzers market is observing a remarkable market growth due to the factors such as the growing prevalence of chronic diseases and the rising burden of geriatric population. Furthermore, the surging demand of early diagnosis of disease, the increasing importance and awareness of point-of-care testing, surging technological advancements in the devices along with the increasing product launches and approvals, presence of key players in the market, and other factors will create a requisite for the clinical chemistry analyzers in the market. Therefore, the market for clinical chemistry analyzers is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

CLINICAL CHEMISTRY ANALYZERS MARKET DYNAMICS:

One of the key aspect for driving the clinical chemistry analyzers market is the rising number of various chronic disease such as cancers, urological, infectious diseases, and others across the globe.

For instance, according to the World Health Organization (WHO) 2022, chronic diseases kills nearly 41 million people each year, equivalent to 74% of all deaths globally. The main types of chronic diseases are cardiovascular diseases such as heart attacks and stroke, cancers, chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma, diabetes, and others.

Also, the same source listed the incidence of cancer in 2020, globally. The most common form of cancers reported was of breast cancer with 2.26 million cases, lung cancer -2.21 million cases, colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, skin cancer 1.20 million cases, and stomach cancer with 1.09 million cases, globally. This increasing incidence of cancers will increase the demand of analyzers as these devices can be employed while diagnosis of the cancers, thereby leading to its increased demand in the market.

Moreover, the rising burden of geriatric population will increase the number of prevalence of various chronic disease, in turn increasing the demand of the clinical chemistry analyzers. As per the study concluded by WHO in 2022, it was clearly stated that by the year 2030, around 1 in 6 people will be over the age of 60. The same source revealed that the number of people over the age of 60 will reach 1.4 billion in the year 2030, up from 1 billion in 2020. The numbers are further projected to rise to 2.1 billion by 2050. The increasing elderly population is vulnerable to several chronic diseases, resulting in high demand for clinical tests. Thus, the clinical chemistry analyzers market is expected to witness high growth over the forecast period.

Moreover, rising product launches and approvals pertaining to the clinical chemistry analyzers will propel the demand of the device in the upcoming years. For instance, in July 2022, EDAN Instruments, Inc., a medical equipment provider that offers medical electronic equipment, launched its point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20, with the capacity to analyze over 45 parameters, covering everything from blood gases to electrolytes to CO-oximetry.

Therefore, the factors stated above collectively will drive the overall clinical chemistry analyzers market during the forecast period from 2024-2030.

However, lack of trained and skilled professionals, high cost of clinical chemistry analyzer devices, and others may prove to be challenging factors for clinical chemistry analyzers market growth.

The clinical chemistry analyzers market was moderately impacted during the period of COVID- 19 pandemic. In order to curb the spread of infection the government across the globe imposed strict lockdown rules, resulting in the shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all the medical devices. Moreover, the patients and physicians postponed many elective surgeries, testing, and diagnosis of diseases in order to stop the spread of the infection, thereby decreasing the number of in-patient visits in hospitals and clinics. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments, management, and diagnosis in hospitals and clinics, thereby bringing the demand for products on track in the clinical chemistry analyzers market.

CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENT ANALYSIS:

Clinical Chemistry Analyzers Market by Product Type (Analyzers, Reagents, and Others), Type of Test (Liver Panels, Electrolyte Panels, Thyroid Function Panels, Lipid Profiles, and Others), Technology (Fully-Automated and Semi- Automated), End User (Hospital, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the clinical chemistry analyzers market, the analyzers segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising number of chronic disease, availability of technological advanced products in the market, rising product launches and approvals in the market, and other advantages offered by the segment.

The analyzers are the instruments that examine the samples, such as blood serum and urine. The automation in analyzers has become universal in clinical laboratories around the world. This advancement will aid in reducing healthcare costs, provides accuracy and reliability. Thus, the hospitals and laboratories rely on automated analyzers in order to maintain profitability as well.

Moreover, the presence of technological advanced products in the market will in-turn increase the demand of analyzers. For instance, Atellica CH 930 Analyzer from Siemens Healthineers is an apt example of a technologically improved Clinical Chemistry analyzer. Atellica Solution integrates immunoassay and clinical chemistry analyzer. With Potentiometric, Photometric, and Turbidimetric Assay Technologies, Atellica CH 930 comes with a feature of auto reflex testing, which means it will perform additional tests based on the first test result. It's a mid-volume clinical chemistry analyzer, capable of running a maximum of 1800 tests per hour.

Furthermore, the increasing product launches in the market will bolster the demand of analyzers in the market. For instance, in September 2022, Roche Diagnostics India launched the Cobas pure integrated solutions analyzer with a smarter system that is particularly suitable for numerous laboratories and hospitals in India. The analyzer allows for better utilization of space and increased delivery of high-medical-value tests for greater patient benefits.

Therefore, owing to the above-mentioned factors, the demand of the analyzers will rises, thereby the category is expected to witness a considerable growth eventually contributing to the overall growth of the global clinical chemistry analyzers market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL CLINICAL CHEMISTRY ANALYZERS MARKET:

Among all the regions, North America is expected to dominate the global clinical chemistry analyzers in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing prevalence of chronic diseases, rising importance of diagnosis and specifically point-of care testing, surging geriatric population in the region, and the presence of key market players in the region, and other factors contribute to the growth of the clinical chemistry analyzers market in North America.

For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, it was stated that the chronic diseases are the leading cause of death and disability every year in the United States. The rising number of chronic diseases in the nation enhances to the growth of clinical chemistry analyzers in the North American region. Thus, the high burden of the target and chronic diseases in the region and increasing demand for early diagnostics are the other major factors that are driving the growth of the studied market in the North American region.

Additionally, according to the Canadian Cancer Society 2022 report, about 229,200 new cancer cases were diagnosed in Canada in 2022, and on average, 628 Canadians were diagnosed with cancer every day, which is further expected to increase in the future. Also, as per the same report, lung, breast, colorectal, and prostate cancer were the most diagnosed types of cancer in Canada. Thus, the increasing prevalence of chronic diseases will increase the demand of clinical chemistry analyzers in the upcoming years as these analyzers are used to conduct assays on the clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to any disease.

Furthermore, the increasing product launches of technological advanced products in the local market, rising investments by the key players in the region, and other activities by the key players in the region will drive the demand of clinical chemistry analyzers in the North America during the forecast period of 2022 - 2028. For instance, in February 2022, Thermo Fisher Scientific partnered with Mindray to provide customers in the United States and Canada with two clinical chemistry analyzers for drug screening in clinical and forensic laboratories. Thermo Fisher and Mindray entered into an agreement to offer the FDA-cleared and Health Canada-approved BS-480 (400 tests/hour) and BA-800M (800 tests/hour) analyzers to toxicology labs.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the clinical chemistry analyzers market.

CLINICAL CHEMISTRY ANALYZERS MARKET KEY PLAYERS:

Some of the key market players operating in the clinical chemistry analyzers market includes Abbott, Beckman Coulter, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Sysmex Europe SE., ELITechGroup, F. Hoffmann-La Roche Ltd., HORIBA Medical, Johnson & Johnson Services, Inc., Randox Laboratories Ltd., Ortho Clinical Diagnostics., Nova Biomedical, BioSystems Diagnostics Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Diatron., EKF Diagnostics Holdings plc, Medica Corporation., Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., and others.

RECENT DEVELOPMENTAL ACTIVITIES IN CLINICAL CHEMISTRY ANALYZERS MARKET:

In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability.

In April 2022, Sysmex Europe launched its new three-part differential system, the XQ-320 XQ-Series Automated Hematology Analyzer. With reliable technology and a new level of usability, the XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments.

In January 2020, Sysmex invested in Astrego Diagnostics for the development of urinalysis solutions.

KEY TAKEAWAYS FROM THE CLINICAL CHEMISTRY ANALYZERS MARKET REPORT STUDY

  • Market size analysis for current clinical chemistry analyzers market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the clinical chemistry analyzers market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global clinical chemistry analyzers market.
  • Various opportunities available for the other competitor in the clinical chemistry analyzers market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current clinical chemistry analyzers market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for clinical chemistry analyzers market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS CLINICAL CHEMISTRY ANALYZERS MARKET REPORT STUDY

  • Clinical chemistry analyzers products providers
  • Research organizations and consulting companies
  • Clinical chemistry analyzers -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in clinical chemistry analyzers
  • Various end users who want to know more about the clinical chemistry analyzers market and latest technological developments in the clinical chemistry analyzers market.

FREQUENTLY ASKED QUESTIONS FOR CLINICAL CHEMISTRY ANALYZERS MARKET:

1. What are clinical chemistry analyzers?

The clinical chemistry analyzers are the devices which run assays on the clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs.

2. What is the global market for Clinical Chemistry Analyzers?

The global clinical chemistry analyzers market was valued at USD 12.38 billion in 2022 and will grow at a CAGR of 4.82% during the forecast period from 2024 to 2030 in order to reach USD 16.39 billion by 2030.

3. What are the drivers for global clinical chemistry analyzers market?

The clinical chemistry analyzers market is witnessing a positive market growth owing to the factors such as the growing prevalence of chronic diseases, rising burden of geriatric population, increasing importance and awareness of point-of-care testing, surging technological advancements in the devices, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the clinical chemistry analyzers market.

4. Who are the key players operating in the global clinical chemistry analyzers market?

Some of the key market players operating in the clinical chemistry analyzers market includes Abbott, Beckman Coulter, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Sysmex Europe SE., ELITechGroup, F. Hoffmann-La Roche Ltd., HORIBA Medical, Johnson & Johnson Services, Inc., Randox Laboratories Ltd., Ortho Clinical Diagnostics., Nova Biomedical, BioSystems Diagnostics Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Diatron., EKF Diagnostics Holdings plc, Medica Corporation., Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., and others.

5. Which region has the highest share in clinical chemistry analyzers market?

Among all the regions, North America is estimated to amass the significant revenue share in the global clinical chemistry analyzers market. This can be ascribed to the increasing prevalence of chronic diseases, rising importance of diagnosis and specifically point-of care testing, and the presence of key market players in the region are the reasons which acts as a supportive factor for the North America clinical chemistry analyzers market growth.

Table of Contents

1. Clinical Chemistry Analyzers Market Report Introduction

2. Clinical Chemistry Analyzers Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Clinical Chemistry Analyzers Market Key Factors Analysis

  • 4.1 Clinical Chemistry Analyzers Market Drivers
    • 4.1.1 Growing prevalence of chronic diseases
    • 4.1.2 Rising burden of geriatric population
    • 4.1.3 Increasing importance and awareness of point-of-care testing
    • 4.1.4 Rising technological advancements in clinical chemistry analyzer
  • 4.2 Clinical Chemistry Analyzers Market Restraints and Challenges
    • 4.2.1 Lack of trained and skilled professionals
    • 4.2.2 High cost of clinical chemistry analyzer devices
  • 4.3 Clinical Chemistry Analyzers Market Opportunities
    • 4.3.1 Increasing demand and awareness about early and accurate diagnosis
    • 4.3.2 Incorporation of artificial intelligence in the devices

5. Clinical Chemistry Analyzers Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market

7. Clinical Chemistry Analyzers Market Layout

  • 7.1 By Product Type
    • 7.1.1 Analyzers
    • 7.1.2 Reagents
    • 7.1.3 Others
  • 7.2 By Type of Test
    • 7.2.1 Liver Panels
    • 7.2.2 Electrolyte Panels
    • 7.2.3 Thyroid Function Panels
    • 7.2.4 Lipid Profiles
    • 7.2.5 Others
  • 7.3 By Technology
    • 7.3.1 Fully-Automated
    • 7.3.2 Semi- Automated
  • 7.4 By End User
    • 7.4.1 Hospital
    • 7.4.2 Diagnostic Laboratories
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.1.2 Canada Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.1.3 Mexico Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.2 Europe
      • 7.5.2.1 France Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.2 Germany Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.3 United Kingdom Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.4 Italy Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.5 Spain Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.6 Rest of Europe Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.2 Japan Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.3 India Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.4 Australia Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.5 South Korea Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.6 Rest of Asia Pacific Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1. Middle East Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.4.2 Africa Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.4.3 South America Clinical Chemistry Analyzers Market in USD million (2021-2030)

8. Clinical Chemistry Analyzers Market Global Company Share Analysis - Key 3-5 Companies

9. Clinical Chemistry Analyzers Market Company and Product Profiles

  • 9.1 Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Beckman Coulter, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Siemens Healthcare Private Limited
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Thermo Fisher Scientific Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Sysmex Europe SE.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 ELITechGroup
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 F. Hoffmann-La Roche Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 HORIBA Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Johnson & Johnson Services, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Randox Laboratories Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Ortho Clinical Diagnostics.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Nova Biomedical
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 BioSystems Diagnostics Pvt. Ltd.,
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 DiaSys Diagnostic Systems GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Diatron.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 EKF Diagnostics Holdings plc
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Medica Corporation.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Trivitron Healthcare
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us